3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
1
Papillomavirus Infections
1
Interventions
Injections
41
Carboplatin
34
Cisplatin
24
Capecitabine
24
Paclitaxel
23
Docetaxel
23
pembrolizumab
21
Oxaliplatin
21
Gemcitabine
20
Pemetrexed
19
Bevacizumab
18
Fluorouracil
13
Irinotecan
12
Cyclophosphamide
12
osimertinib
9
Nivolumab
8
Dexamethasone
8
tislelizumab
7
Topotecan
7
Leucovorin
7
Doxorubicin
7
130-nm albumin-bound paclitaxel
7
venetoclax
6
toripalimab
6
regorafenib
6
lenvatinib
6
fludarabine
6
Rituximab
6
Cetuximab
6
daratumumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
INDUSTRY
×
Carbon-14
×
Clear all
NCT06672653
2024-11-04
PREPAP
MGB Pharma
Phase 1/2
Not yet recruiting
66 enrolled